The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and ...

Maky Zanganeh became a billionaire after shares of Summit Therapeutics, where she serves as co-CEO, soared following positive ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Nearly 200 chemicals connected to breast cancer are used in the making of food packaging and plastic tableware, and dozens of ...

Alla Pinzour says she's a trouper. She has lived with melanoma for 15 years. A new therapy offered at the University of ...

Multiple myeloma (MM) is a type of blood cancer that typically has no cure. Treatments like medications and stem cell ...

KRAS is the most mutated gene in cancer with mutations occurring in 17%–25% of all cancers, affecting millions of patients worldwide. It plays a crucial role in tumor growth, as it is important for ...

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving ...

The U.S. Food and Drug Administration (FDA) issued this week three guidance documents related to clinical trials: a draft ...

To help clinical trial sponsors who are planning global cancer studies best position themselves for FDA approval, the agency ...